Scheffers, M. http://orcid.org/0000-0003-0469-1569
Kalisvaart, H.
van Busschbach, J. T.
Bosscher, R. J.
van Duijn, M. A. J.
van Broeckhuysen-Kloth, S. A. M.
Schoevers, R. A.
Geenen, R.
Article History
Received: 1 November 2017
Accepted: 10 October 2018
First Online: 22 October 2018
Ethics approval and consent to participate
: Patients completed the DBIQ as part of a routine initial diagnostic screening and provided written informed consent for the use of the data for scientific purposes. This part of the study protocol was approved by the institutional review board (CWO) of Altrecht, Zeist, the Netherlands (CWOnr 1419). The study in the general population was conducted in agreement with the VU University Amsterdam guideline for research for educational purposes, allowing students to collect data with the use of questionnaires in healthy groups of respondents when participation is voluntary and data are analyzed anonymously. The Medical Ethics Review Committee of VU University waived the requirement for approval according to the Medical Research in Human Subjects Act (in the Netherlands ‘WMO’) (for more details and waiver see reference [CitationRef removed]).
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.